Paper
Document
Download
Flag content
0

Serum IL-6 concentration is a useful biomarker to predict the efficacy of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma

0
TipTip
Save
Document
Download
Flag content


Best
Best
Newest
Upvoted
Start the discussion.
This paper has not yet been discussed.